Consensus SI-BONE, Inc.

Equities

SIBN

US8257041090

Market Closed - Nasdaq Other stock markets 01:30:00 01/05/2024 am IST			5-day change	1st Jan Change
14.26 ^USD	-2.66%		-6.61%	-32.06%

28/03	Piper Sandler Initiates SI-Bone With Overweight Rating, Price Target is $25	MT
12/03	Transcript : SI-BONE, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 08:30 AM

Evolution of the average Target Price on SI-BONE, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e0ea3b8a0ea.yoH3b9Or6UmsHlRmqusKWME45q7vFQnF8f51Qgco5Gk.-PatLJHfgw2fZGwu2bxOaoJxs52oeUSRhLk_CGNBsBCd-M4VgcaiFp9_AQ~39db4d3a94eb474a91a1ae68fb4211ef

Analyst Recommendations on SI-BONE, Inc.

Piper Sandler Initiates SI-Bone With Overweight Rating, Price Target is $25	28/03	MT
Morgan Stanley Raises SI-Bone Price Target to $26 From $25, Maintains Overweight Rating	27/02	MT
Truist Securities Adjusts SI-Bone Price Target to $24 From $26, Maintains Buy Rating	27/02	MT
Truist Securities Adjusts Price Target on SI-Bone to $26 From $25, Maintains Buy Rating	22/12	MT
Truist Securities Raises SI-Bone Price Target to $25 From $22, Maintains Buy Rating	12/12	MT
Cantor Fitzgerald Adjusts SI-Bone's Price Target to $25 From $30, Maintains Overweight Rating	07/11	MT
Morgan Stanley Adjusts Price Target on SI-Bone to $25 From $30, Maintains Overweight Rating	07/11	MT
Needham Adjusts Price Target on SI-Bone to $25 From $32, Maintains Buy Rating	07/11	MT
BofA Trims Price Target on SI-Bone to $24 From $33, Keeps Buy Rating	18/23/18	MT
Truist Securities Adjusts Price Target on SI-Bone to $33 From $28, Maintains Buy Rating	19/23/19	MT
Needham Adjusts Price Target on SI-Bone to $32 From $27, Maintains Buy Rating	12/23/12	MT
Morgan Stanley Adjusts Price Target on SI-Bone to $30 From $27, Maintains Overweight Rating	31/23/31	MT
Morgan Stanley Adjusts Price Target on SI-Bone to $27 From $22, Maintains Overweight Rating	02/23/02	MT
Cantor Fitzgerald Adjusts Price Target on SI-Bone to $30 From $24, Maintains Overweight Rating	02/23/02	MT
Needham Adjusts Price Target on SI-Bone to $27 From $24, Maintains Buy Rating	02/23/02	MT
Canaccord Genuity Raises Price Target on SI-Bone to $27 From $24, Maintains Buy Rating	02/23/02	MT
Truist Securities Adjusts Price Target on SI-Bone to $26 From $21, Maintains Buy Rating	28/23/28	MT
Needham Adjusts Price Target on SI-Bone to $24 From $20, Maintains Buy Rating	28/23/28	MT
Morgan Stanley Adjusts Price Target on SI-Bone to $22 From $18, Maintains Overweight Rating	28/23/28	MT
Canaccord Genuity Adjusts Price Target on SI-Bone to $24 From $21, Maintains Buy Rating	28/23/28	MT
Cantor Fitzgerald Adjusts Price Target on SI-Bone to $24 From $22, Maintains Overweight Rating	28/23/28	MT
Truist Securities Adjusts Price Target on SI-Bone to $21 From $17, Maintains Buy Rating	31/23/31	MT
Morgan Stanley Adjusts Price Target on SI-Bone to $18 From $21, Maintains Overweight Rating	06/23/06	MT
Truist Securities Adjusts Price Target on SI-Bone to $17 From $20, Maintains Buy Rating	20/22/20	MT
Morgan Stanley Adjusts Price Target on SI-Bone to $21 From $22, Maintains Overweight Rating	08/22/08	MT